These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 23246797)

  • 1. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin.
    Taupitz T; Dressman JB; Klein S
    Eur J Pharm Biopharm; 2013 May; 84(1):208-18. PubMed ID: 23246797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions.
    Zoeller T; Dressman JB; Klein S
    Int J Pharm; 2012 Jul; 430(1-2):176-83. PubMed ID: 22531855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro tools for evaluating novel dosage forms of poorly soluble, weakly basic drugs: case example ketoconazole.
    Taupitz T; Dressman JB; Klein S
    J Pharm Sci; 2013 Oct; 102(10):3645-52. PubMed ID: 23873592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation.
    Karim A; Zhao Z; Slater M; Bradford D; Schuster J; Laurent A
    J Clin Pharmacol; 2007 Jul; 47(7):806-16. PubMed ID: 17463215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes.
    Elbary AA; Kassem MA; Abou Samra MM; Khalil RM
    Drug Discov Ther; 2008 Apr; 2(2):94-107. PubMed ID: 22504505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin.
    Riekes MK; Engelen A; Appeltans B; Rombaut P; Stulzer HK; Van den Mooter G
    Pharm Res; 2016 May; 33(5):1259-75. PubMed ID: 26857899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
    Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
    Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in rats.
    Du B; Shen G; Wang D; Pang L; Chen Z; Liu Z
    Drug Deliv; 2013; 20(1):25-33. PubMed ID: 23311650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
    Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
    Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
    Jiang T; Han N; Zhao B; Xie Y; Wang S
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state.
    Jug M; Mennini N; Kövér KE; Mura P
    J Pharm Biomed Anal; 2014 Mar; 91():81-91. PubMed ID: 24444785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.